The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Xiaozhang Tie Improves Intestinal Motility in Rats With Cirrhotic Ascites by Regulating the Stem Cell Factor/c-kit Pathway in Interstitial Cells of Cajal
Open accessAbstract
We previously discovered that Xiaozhang Tie (XZT) was helpful for cirrhotic ascites, with obvious abdominal distention relief, suggesting that it may improve gastrointestinal (GI) motility. However, the underlying mechanisms of GI motility in cirrhotic ascites are unclear. Here, we aimed to discover explored the effect of XZT on GI motility in animal cirrhotic ascites and probed the action mechanism affecting GI motility by regulating the SCF/c-kit pathway in ICCs and GI hormones. First, rat models of cirrhotic ascites were developed and then divided randomly into the following three subgroups: model control, XZT group, and mosapride group. The efficacy of XZT on treating cirrhotic ascites was evaluated on the basis of ascites weight and volume, 24 h urine volume, and feces water content. GI motility, intestine propulsion and gartric residue were detected using the migration distance of ink in vivo, and the frequency of contraction and tension of isolated gastric and jejunal muscle strips were measured after incubation with XZT extracts. Serum GI hormone content, including motilin (MTL), substance P (SP), somatostain (SS), and vasoactive intestinal polypeptide were assayed. Subsequently, ICCs were isolated from jejunum, and primarily cultured ICCs were incubated with and without XZT and SCF. The cell vitality of the ICCs was measured. A whole-cell patch recording technique was used to record the current of K+ and Na+ channels in the ICC membrane. Expressions of c-kit/p-c-kit, p-Akt, p-Stat3, and p-Erk1/2 were detected in vivo and in vitro. The results revealed that XZT significantly reduced ascites weight and increased urine volume and fecal water content in model rats. XZT promoted intestinal motility and increased MTL level but reduced SP and SS levels. It enhanced the current of Na+ and K+ in ICCs and improved c-kit expression and signaling mediator phosphorylation in SCF/c-kit, which was inhibited by imatinib in vitro and downregulated in model rats in vivo. Our study concluded that XZT reduced the amount of ascites and improved intestinal motility in cirrhotic rats, which may be associated with its effect on ascites and was involved in the mechanisms regulating the SCF/c-Kit signaling pathway in ICCs and improving gastrointestinal hormone secretion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Management of adult patients with ascites due to cirrhosis: An update†‡§
Runyon, B. A. (2009) · Hepatology · doi:10.1002/hep.22853 · Cited by 975
Natural History of Patients Hospitalized for Management of Cirrhotic Ascites
Planas, R., Montoliu, S., Ballesté, B., Rivera, M., Miquel, M., Masnou, H., Galeras, J. A., Giménez, M. D., Santos, J., Cirera, I., et al. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.08.007 · Cited by 401
Delayed gastric emptying in patients with liver cirrhosis
Isobe, H., Sakai, H., Satoh, M., Sakamoto, S., & Nawata, H. (1994) · Digestive Diseases and Sciences · doi:10.1007/bf02087548 · Cited by 58
López-Talavera, J. C., Levitzki, A., Martinez, M., Gazit, A., Esteban, R., & Guàrdia, J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119578 · Cited by 50
Kalaitzakis, E., Sadik, R., Holst, J. J., Öhman, L., & Bjornsson, E. S. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.11.022 · Cited by 47
Roland, B. C., García–Tsao, G., Ciarleglio, M. M., Deng, Y., & Sheth, A. A. (2013) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31829006bb · Cited by 45
Communication between interstitial cells of Cajal and gastrointestinal muscle
Daniel, E. E. (2004) · Neurogastroenterology & Motility · doi:10.1111/j.1743-3150.2004.00486.x · Cited by 36
Management of ascites in patients with liver cirrhosis: Recent evidence and controversies
Hsu, S., & Huang, H. (2013) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2012.11.005 · Cited by 33
Ros, J., Fernández‐Varo, G., Muñoz, J., Arroyo, V., Rodés, J., Gunnet, J. W., Demarest, K. T., & Jiménez, W. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706375 · Cited by 14
Cited by
The interplay of ROS and the PI3K/Akt pathway in autophagy regulation
Kma, L., & Baruah, T. J. (2022) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2104 · Cited by 394
Hernandez, J. L., & Woodrow, K. A. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202102087 · Cited by 259
Dhakal, A., McKay, C., Tanner, J. J., & Cheng, J. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbab476 · Cited by 256
Chen, Y.-G., He, X.-L.-S., Huang, J.-H., Luo, R., Ge, H.-Z., Wołowicz, A., Wawrzkiewicz, M., Gładysz-Płaska, A., Li, B., Yu, Q.-X., et al. (2021) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2021.112336 · Cited by 192
Shen, Y., Teng, L., Qu, Y., Liu, J., Zhu, X., Chen, S., Yang, L., Huang, Y., Song, Q., & Fu, Q. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114791 · Cited by 113
MDM2/X inhibitors as radiosensitizers for glioblastoma targeted therapy
Miles, X., Vandevoorde, C., Hunter, A., & Bolcaen, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.703442 · Cited by 40
Mechanisms involved in the anti-tumor effects of Toosendanin in glioma cells
Zhang, C., Gao, H., Liu, Z., Lai, J., Zhan, Z., Chen, Y., & Huang, H. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02186-2 · Cited by 21
Metadata
- Authors
- Zhao, Q., Xing, F., Tao, Y., Liu, H., Huang, K., Peng, Y., Feng, N., & Liu, C.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2020-02-04
- Volume
- 11
- Pages
- 1-1
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W2997998095
- Cited by
- 293
- References
- 10
- FWCI
- 42.76
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.